Screener
Kymera Therapeutics KYMR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's current ratio?
- Kymera Therapeutics (KYMR) reported current ratio of 10.3× in Q2 2026.
- How has Kymera Therapeutics's current ratio changed year-over-year?
- Kymera Therapeutics's current ratio increased by 24.2% year-over-year, from 8.3× to 10.3×.
- What is the long-term trend for Kymera Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Kymera Therapeutics's current ratio has grown at a 30.8% compound annual growth rate (CAGR), from 2.7× to 10.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Kymera Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude